Literature DB >> 11854318

Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice.

Joachim Pohlenz1, Alexandra Dumitrescu, Dorothee Zundel, Ursula Martiné, Winfried Schönberger, Eugene Koo, Roy E Weiss, Ronald N Cohen, Shioko Kimura, Samuel Refetoff.   

Abstract

Three genes, TTF1, TTF2, and PAX8, involved in thyroid gland development and migration have been identified. Yet systematic screening for defects in these genes in thyroid dysgenesis gave essentially negative results. In particular, no TTF1 gene defects were found in 76 individuals with thyroid dysgenesis even though a deletion of this gene in the mouse results in thyroid and lung agenesis and defective diencephalon. We report a 6-year-old boy with predominant dyskinesia, neonatal respiratory distress, and mild hyperthyrotropinemia. One allele of his TTF1 gene had a guanidine inserted into codon 86 producing a nonsense protein of 407, rather than 371, amino acids. The mutant TTF1 did not bind to its canonical cis-element or transactivate a reporter gene driven by the thyroglobulin promoter, a natural target of TTF1. Failure of the mutant TTF1 to interfere with binding and transactivation functions of the wild-type TTF1 suggested that the syndrome was caused by haploinsufficiency. This was confirmed in mice heterozygous for Ttf1 gene deletion, heretofore considered to be normal. Compared with wild-type littermates, Ttf1(+/-) mice had poor coordination and a significant elevation of serum thyrotropin. Therefore, haploinsufficiency of the TTF1 gene results in a predominantly neurological phenotype and secondary hyperthyrotropinemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854318      PMCID: PMC150877          DOI: 10.1172/JCI14192

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure.

Authors:  N Iwatani; H Mabe; K Devriendt; M Kodama; T Miike
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

2.  Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone.

Authors:  J Pohlenz; A Maqueem; K Cua; R E Weiss; J Van Sande; S Refetoff
Journal:  Thyroid       Date:  1999-12       Impact factor: 6.568

3.  Autosomal dominant transmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX8.

Authors:  C Vilain; C Rydlewski; L Duprez; C Heinrichs; M Abramowicz; P Malvaux; B Renneboog; J Parma; S Costagliola; G Vassart
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

4.  TTF-1, a homeodomain gene required for diencephalic morphogenesis, is postnatally expressed in the neuroendocrine brain in a developmentally regulated and cell-specific fashion.

Authors:  B J Lee; G J Cho; R B Norgren; M P Junier; D F Hill; V Tapia; M E Costa; S R Ojeda
Journal:  Mol Cell Neurosci       Date:  2001-01       Impact factor: 4.314

5.  Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone.

Authors:  P Beck-Peccoz; S Amr; M M Menezes-Ferreira; G Faglia; B D Weintraub
Journal:  N Engl J Med       Date:  1985-04-25       Impact factor: 91.245

6.  Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency.

Authors:  Heiko Krude; Barbara Schütz; Heike Biebermann; Arpad von Moers; Dirk Schnabel; Heidi Neitzel; Holger Tönnies; Dagmar Weise; Antony Lafferty; Siegfried Schwarz; Mario DeFelice; Andreas von Deimling; Frank van Landeghem; Roberto DiLauro; Annette Grüters
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

7.  Human, bovine, canine and rat thyroglobulin promoter sequences display species-specific differences in an in vitro study.

Authors:  A Donda; F Javaux; P Van Renterghem; C Gervy-Decoster; G Vassart; D Christophe
Journal:  Mol Cell Endocrinol       Date:  1993-01       Impact factor: 4.102

8.  A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter.

Authors:  D Civitareale; R Lonigro; A J Sinclair; R Di Lauro
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

9.  PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors.

Authors:  A Poleev; H Fickenscher; S Mundlos; A Winterpacht; B Zabel; A Fidler; P Gruss; D Plachov
Journal:  Development       Date:  1992-11       Impact factor: 6.868

10.  Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity.

Authors:  S Guazzi; M Price; M De Felice; G Damante; M G Mattei; R Di Lauro
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

View more
  58 in total

Review 1.  Transcription factor haploinsufficiency: when half a loaf is not enough.

Authors:  J G Seidman; Christine Seidman
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  Sequence-specific DNA binding by the vnd/NK-2 homeodomain of Drosophila.

Authors:  Lan-Hsiang Wang; Rebecca Chmelik; Marshall Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-13       Impact factor: 11.205

3.  Unique ability of pandemic influenza to downregulate the genes involved in neuronal disorders.

Authors:  Esmaeil Ebrahimie; Zahra Nurollah; Mansour Ebrahimi; Farhid Hemmatzadeh; Jagoda Ignjatovic
Journal:  Mol Biol Rep       Date:  2015-08-06       Impact factor: 2.316

Review 4.  Detection and treatment of congenital hypothyroidism.

Authors:  Annette Grüters; Heiko Krude
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

5.  Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively.

Authors:  Jia Liu; Su Dong; Heather Wang; Lian Li; Qinmao Ye; Yanhui Li; Jiaxing Miao; Sissy Jhiang; Jing Zhao; Yutong Zhao
Journal:  FASEB J       Date:  2019-06-25       Impact factor: 5.191

6.  A mutation in TTF1/NKX2.1 is associated with familial neuroendocrine cell hyperplasia of infancy.

Authors:  Lisa R Young; Gail H Deutsch; Ronald E Bokulic; Alan S Brody; Lawrence M Nogee
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

Review 7.  The molecular causes of thyroid dysgenesis: a systematic review.

Authors:  I C Nettore; V Cacace; C De Fusco; A Colao; P E Macchia
Journal:  J Endocrinol Invest       Date:  2013-05-22       Impact factor: 4.256

Review 8.  The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.

Authors:  Silvia Ravera; Andrea Reyna-Neyra; Giuseppe Ferrandino; L Mario Amzel; Nancy Carrasco
Journal:  Annu Rev Physiol       Date:  2017-02-10       Impact factor: 19.318

9.  Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis.

Authors:  Aurore Carré; Mireille Castanet; Sylvia Sura-Trueba; Gabor Szinnai; Guy Van Vliet; Delphine Trochet; Jeanne Amiel; Juliane Léger; Paul Czernichow; Virginie Scotet; Michel Polak
Journal:  Hum Genet       Date:  2007-08-24       Impact factor: 4.132

10.  Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells.

Authors:  Miguel A Zaballos; Bibian Garcia; Pilar Santisteban
Journal:  Mol Endocrinol       Date:  2008-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.